Amedisys, Inc. (AMED) Insider Trading Activity

NASDAQ$100.99
Market Cap
$3.32B
Sector
Healthcare
Industry
Medical—Care Facilities
Rank in Sector
—
Rank in Industry
—

AMED Insider Trading Activity

AMED Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$
–
Sells
$
–

Related Transactions

About Amedisys, Inc.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

Insider Activity of Amedisys, Inc.

Over the last 12 months, insiders at Amedisys, Inc. have bought $undefined and sold $undefined worth of Amedisys, Inc. stock.

On average, over the past 5 years, insiders at Amedisys, Inc. have bought $400,626 and sold $2.16M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,000 shares for transaction amount of $141,250 was made by LECHLEITER RICHARD A (director) on 2021‑11‑30.

List of Insider Buy and Sell Transactions, Amedisys, Inc.

2025-05-08Sale
Guidroz Allyson
Chief Accounting Officer
374
0.0011%
$96.00
$35,904
+2.28%
2025-03-04Sale
Guidroz Allyson
Chief Accounting Officer
2,041
0.0062%
$92.03
$187,833
+2.84%
2023-03-03Sale
North Michael Paul
Chief Information Officer
5,908
0.0176%
$86.43
$510,628
+4.04%
2022-06-23Sale
Bohnert Denise M.
Chief Compliance Officer
557
0.0017%
$115.00
$64,055
-20.74%
2022-03-29Sale
Kemmerly David L
See Remarks
443
0.0014%
$177.89
$78,805
-42.41%
2021-11-30Purchase
LECHLEITER RICHARD A
director
1,000
0.0031%
$141.25
$141,250
-11.92%
2021-09-01Sale
PERKINS BRUCE D
director
11,511
0.0351%
$183.00
$2.11M
-21.80%
2021-08-02Sale
Gerard Christopher
President & COO
1,250
0.0039%
$261.24
$326,544
-41.61%
2021-07-01Sale
Gerard Christopher
President & COO
1,250
0.0037%
$250.90
$313,622
-39.89%
2021-06-01Sale
Gerard Christopher
President & COO
1,250
0.0038%
$256.62
$320,771
-37.28%
2021-05-28Sale
Ginn Scott G
EVP & Chief Financial Officer
975
0.003%
$261.60
$255,060
-36.89%
2021-05-25Sale
Gerard Christopher
President & COO
1,250
0.0038%
$259.59
$324,488
-36.86%
2021-04-30Sale
Ginn Scott G
EVP & Chief Financial Officer
975
0.0031%
$283.33
$276,247
-37.99%
2021-04-27Sale
Kemmerly David L
See Remarks
4,875
0.0152%
$290.12
$1.41M
-41.17%
2021-04-27Sale
North Michael Paul
Chief Information Officer
1,731
0.0054%
$290.02
$502,025
-41.17%
2021-04-09Sale
Kemmerly David L
See Remarks
500
0.0015%
$280.00
$140,000
-39.55%
2021-04-01Sale
Kemmerly David L
See Remarks
503
0.0015%
$270.00
$135,810
-35.48%
2021-03-31Sale
Ginn Scott G
EVP & Chief Financial Officer
975
0.0029%
$260.40
$253,890
-34.28%
2021-03-01Purchase
PERKINS BRUCE D
director
1,000
0.0031%
$259.38
$259,376
-28.36%
2021-02-26Sale
Ginn Scott G
EVP & Chief Financial Officer
975
0.0031%
$264.15
$257,546
-27.86%
Total: 311
*Gray background shows transactions not older than one year

AMED Institutional Investors: Active Positions

Increased Positions00%00%
Decreased Positions00%00%
New Positions0New0New
Sold Out Positions0Sold Out0Sold Out
Total Postitions00%00%

AMED Ownership Change vs Market

No data is available at this moment.

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.